Casa
scp 666 1/2 j

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years

Por um escritor misterioso

Descrição
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Understanding the Magic of the Endocannabinoid System – Hempy Longstocking
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition - David Panikashvili, Raphael Mechoulam, Sara M Beni, Alexander Alexandrovich, Esther Shohami, 2005
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure - ScienceDirect
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
American Society for Pharmacology and Experimental Therapeutics - ASPET on LinkedIn: #neurodegenerative #pharmacologicalreviews #pharmacology
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Correction to “Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years”
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Visualizing lipid receptor localization and activation. (A) CB1 and CB2
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Changes in endocannabinoid levels 1 h after oral administration of
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Biomedicines, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)